ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
143.59
-0.75 (-0.52%)
May 13, 2025, 4:00 PM - Market closed
ICU Medical Revenue
ICU Medical had revenue of $604.70M in the quarter ending March 31, 2025, with 6.71% growth. This brings the company's revenue in the last twelve months to $2.42B, up 7.22% year-over-year. In the year 2024, ICU Medical had annual revenue of $2.38B with 5.44% growth.
Revenue (ttm)
$2.42B
Revenue Growth
+7.22%
P/S Ratio
1.45
Revenue / Employee
$161,340
Employees
15,000
Market Cap
3.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.38B | 122.92M | 5.44% |
| Dec 31, 2023 | 2.26B | -20.87M | -0.92% |
| Dec 31, 2022 | 2.28B | 963.69M | 73.21% |
| Dec 31, 2021 | 1.32B | 45.30M | 3.56% |
| Dec 31, 2020 | 1.27B | 4.80M | 0.38% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ICUI News
- 3 days ago - ICU Medical, Inc. (ICUI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Shareholders to Reach Out - Accesswire
- 5 days ago - ICU Medical, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm - Accesswire
- 5 days ago - ICU Medical Announces First Quarter 2025 Results - GlobeNewsWire
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 6 days ago - ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Shareholders to Inquire about Securities Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Investors to Connect - Accesswire